Treatment of acute promyelocytic leukemia: A single institution experience. Tratamiento de la leucemia promielocítica aguda. Experiencia de una sola institución. A collection of disease information resources and questions answered by our Genetic and Rare Diseases Information Specialists for Acute promyelocytic. A leucemia promielocítica aguda (LPA) é um subtipo distinto de leucemia mieloide aguda (LMA), caracterizado pela presença de um acúmulo de promielócitos.
|Published (Last):||18 October 2010|
|PDF File Size:||4.39 Mb|
|ePub File Size:||6.53 Mb|
|Price:||Free* [*Free Regsitration Required]|
Currently, the patient is incomplete remission and a recent cytogenetics test does not show the t 15; All-trans retinoic acid in the treatment of acute promyelocytic leukemia. Role of maintenance chemotherapy in acute promyelocytic leukemia. All transretinoic acid ATRA. Rearrangements of the retinoic acid receptor leudemia and promyelocytic leukemia zinc finger genes resulting from t 11;17 q23;q21 in a patient with acute promyelocytic leukemia.
Additional chromosome aberrations in acute promyelocit leukemia: Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia.
Fibrinogenopenia and promielocitiica in acute prkmielocitica leukemia. Results from several randomized studies have evaluated various regimens of ATRA alone or in combination with CT to determine optimal induction therapy in patients with newly diagnosed APL.
The method which we have previously published and employed to treat patients with PML, 13 includes prednisone during the first three weeks of treatment; this addition has resulted in the eradication of the ATRA syndrome, which in our hands is no longer promielocitjca problem; prospective studies to define the definite role of steroids in this setting are needed.
Promyelocytic leukemia in Mexican mestizos. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols.
Report of the first Latin American consensus conference for flow cytometric immunophenotyping of leukemia. Normal levevel of antithrobin III in acute leukemia complicated by coagulopathy. The greatest cause of death was severe bleeding, especially in the central nervous system CNS.
Orphanet: Leucemia promielocitica acuta
Early mortality represents almost all deaths and severe bleeding was the most important event leading to death. Trisomy 21 and other chromosomal abnormalities in acute promyelocytic leukemia. The according with results, the patients were classified following: Alterations of the FLT3 gene in acute promyelocytic leukemia: Disease definition Acute promyelocytic leukemia APL is an aggressive form of acute myeloid leukemia AML; see this termcharacterized by arrest of leukocyte differentiation at the promyelocyte stage, due to a specific chromosomal translocation t 15;17 in myeloid cells.
Cellular immunophenotypes in 97 adults with acute leukemia. The molecular remission was achieved after the administration of ATRA in five patients, whereas in the remaining eight, chemotherapy Promieolcitica was required to finally achieve it.
Abnormalities in hemostasis in acute promyelocytic leukemia. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.
Trombose arterial em leucemia promielocítica aguda
The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, promielcoitica only one rate limiting mutation. Detailed information Article for general public Deutsch High frequency of acute promyelocyitic leukemia in Mexican Mestizos.
The impact of medical education and networking on the outcome of leukemia treatment in developing countries.
Early mortality occurred in Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia. Arterial thrombosis in acute promyelocytic leukemia.
APL manifests with easy bruising, hemorrhagic diathesis promielocitic fatigue. How acute promyelocytic leukaemia revived arsenic.
Leuk Lymphoma ; Molecular evaluation of response to all-trans-retinoic acid therapy in patients with acute promyelocytic leukemia. Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: Other factors identified to be associated with an adverse outcome include CD56 expression and advanced age.
Health care resources for this disease Expert centres Diagnostic tests Patient organisations 42 Orphan drug s Who Classification of tumours of haematopoietic and lymphoid tissues. Easy bruising or hemorrhagic diathesis epistaxis, gums bleeding, hematuria, petechiae, metroragia are frequently observed. Treatment of promielofitica diagnosed acute promyelocytic leukemia APL: Adult acute myeloid leukemia: Only comments written in English can be processed.
¿Qué sucede si la leucemia mieloide aguda (AML) no responde o regresa después del tratamiento?
High frequency of acute promyelocytic leukemia among latinos with acute myeloid leukemia Letter. Aceptado el 6 de abril de Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR blockade in the pathogenesis of acute promyelocytic leukemia.
Treatment of acute promyelocytic leukemia with Arsenic compounds: Nonparametric estimations from incomplete observations. Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: Vasco de Quiroga No.